SCHEMBL4756010

SCHEMBL4756010

O=C(Nc1nccs1)c1ccccc1OS(=O)(=O)c1ccccc1F

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.58
MAPK1 P28482 1/20 0.58
CYP1A2 P05177 1/20 0.53
GLA P06280 1/20 0.53
NPC1 O15118 4/20 0.52
RAB9A P51151 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
ALDH1A1 P00352 2/20 0.52
GAA P10253 2/20 0.52
HTT P42858 1/20 0.50
PKM P14618 1/20 0.49
HPGD P15428 1/20 0.49
MGAM O43451 1/20 0.47
SI P14410 1/20 0.47
MGAM2 Q2M2H8 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756138 0.87 ALOX15 (0.61) ALOX15MAPK1CYP1A2GLANPC1
SCHEMBL703469 0.82 ALOX15 (0.70) ALOX15MAPK1CYP1A2GLANPC1
SCHEMBL419202 0.80 CYP1A2 (0.71) ALOX15MAPK1CYP1A2NPC1RAB9A
SCHEMBL419203 0.76 MAPK1 (0.76) ALOX15MAPK1CYP1A2NPC1RAB9A
SCHEMBL416630 0.76 ALOX15 (0.67) ALOX15MAPK1CYP1A2NPC1RAB9A
Bromide SCHEMBL27908055 0.75 MAPK1 (0.74) ALOX15MAPK1CYP1A2NPC1RAB9A
SCHEMBL4965216 0.75 CYP1A2 (0.63) ALOX15MAPK1CYP1A2NPC1RAB9A
SCHEMBL16363830 0.74 MAPK1 (1.00) ALOX15MAPK1CYP1A2NPC1RAB9A
SCHEMBL714175 0.74 MAPK1 (0.73) ALOX15MAPK1CYP1A2NPC1RAB9A
SCHEMBL18026621 0.74 ALOX15 (0.76) ALOX15MAPK1CYP1A2GLANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
WO-2009035788-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. (US) 2009-03-19 WO disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC ALOX15 4222/4885MAPK1 3595/4885CYP1A2 2853/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC ALOX15 4222/4885MAPK1 3595/4885CYP1A2 2853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.